Search results for "rex"

showing 10 items of 701 documents

A Differentiated European Union

2020

Differentiation in the EU has substantially increased. It does not only refer to instances of (differentiation in) integration, but also (potential) disintegration. Differentiation can often be causally traced back to crises, yet it should not be equated with ‘crisis’. However, the literature has only scarcely discussed the putative link between crisis and differentiated integration. Fundamentally, demands for differentiation need to be treated as both a cause and an effect of integration. Thus, differentiation should be acknowledged as a persistent feature of European integration. The chapter discusses the development of differentiation in European integration and reflects upon the scholar…

BrexitPolitical sciencePolitical economyEuropean integrationmedia_common.cataloged_instanceEuropean unionmedia_common
researchProduct

Conclusion

2019

Brexitbusiness.industryPolitical scienceInternational tradebusiness
researchProduct

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H…

2020

Abstract Objectives Given a lack of universally-accepted standard-of-care treatment for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), study objectives were to assess treatment utilization and survival outcomes for R/M HNSCC in the real-world setting. Materials and methods A multi-site retrospective chart review was conducted in Europe (Germany, United Kingdom, Italy, Spain), Asia Pacific (Australia, South Korea, Taiwan), and Latin/North America (Brazil and Canada) to identify patients who initiated first-line systemic therapy for R/M HNSCC between January 2011 and December 2013. Patients were followed through December 2015 to collect clinical characte…

Bridged-Ring CompoundsMaleCanadaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentTaiwanMedizinCetuximabPlatinum CompoundsKaplan-Meier EstimateSystemic therapy03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsRepublic of KoreaConfidence IntervalsmedicineHumans030223 otorhinolaryngologySurvival analysisAgedRetrospective StudiesChemotherapyCetuximabSquamous Cell Carcinoma of Head and Neckbusiness.industryHead and neck cancerAustraliaMiddle Agedmedicine.diseaseHead and neck squamous-cell carcinomaConfidence intervalEuropeRegimenMethotrexateTreatment OutcomeOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisFemaleTaxoidsFluorouracilNeoplasm Recurrence LocalOral SurgerybusinessBrazilmedicine.drugOral Oncology
researchProduct

Medical management of Crohn's disease

2011

The medical approach to Crohn's disease has been modified in recent years thanks to the introduction of new therapies, like biologics. Also, well-designed studies and systematic reviews have allowed better evaluation of the role of old drugs like steroids and immunosuppressors. This review aims to evaluate the recent evidence on the medical approach to Crohn's disease in the different settings of the disease.Randomized controlled trials and meta-analyses were included in the review. The research on all the studies discussed was based on the Cochrane Library, Medline and Embase, using the following medical subject headings: Crohn's disease, clinical trial, therapy, 5-aminosalicylic acid, ste…

Budesonidemedicine.medical_specialtyPathologyAnti-Inflammatory AgentsMEDLINEDiseaseCochrane LibraryManagement of Crohn's diseaselaw.inventionCrohn DiseaseRandomized controlled trialAdrenal Cortex HormoneslawmedicineHumansPharmacology (medical)BudesonideIntensive care medicineBone Marrow TransplantationPharmacologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsIntestinesClinical trialAminosalicylic AcidsMethotrexateTreatment OutcomeSystematic reviewPurinesbusinessImmunosuppressive Agentsmedicine.drugExpert Opinion on Pharmacotherapy
researchProduct

What happens in the course of body exposure?

2007

Abstract Objective Though body exposure seems to enhance outcome in cognitive-behavioural therapy of anorexia and bulimia nervosa, the underlying mechanisms are still unknown. Methods Participants with eating disorders (ED; n = 21) and normal controls (NC; n = 28) were exposed to their own bodies in front of a mirror for 40 minutes under standardized conditions. Emotions, cognitions, and saliva cortisol were assessed every 10 minutes during body exposure. Heart rate and skin conductance were recorded continuously. Results ED showed higher negative emotional and cognitive responses to body exposure compared to NC, whereas no group differences were found for physiological reactions. In the co…

Bulimia nervosaCognitionAnorexiamedicine.diseaseAnorexia nervosaAffect (psychology)Developmental psychologyArousalPsychiatry and Mental healthClinical PsychologyEating disordersmedicinemedicine.symptomPsychologyBody mass indexClinical psychologyJournal of Psychosomatic Research
researchProduct

Pacientu ar ēšanas traucējumiem klīniski diagnostiskais raksturojums un ārstēšanas specifika VSIA Bērnu Klīniskās Universitātes slimnīcā Bērnu psihia…

2017

Pacientu ar ēšanas traucējumiem klīniski diagnostiskais raksturojums un ārstēšanas specifika VSIA Bērnu Klīniskās Universitātes slimnīcā Bērnu psihiatrijas klīnikas stacionārajā nodaļā 2011.–2016. gadā Ilze Elizabete Ošeniece, dr. Ņikita Bezborodovs Latvijas Universitāte, Medicīnas fakultāte Ēšanas traucējumi ir bieži novērojami, un tas var būt potenciāli nāvējošs stāvoklis. Jauniešiem ēšanas traucējumi attīstās saistībā ar psihiskiem stāvokļiem tādiem kā: trauksme, depresija, narkotiku lietošana, paškaitīga uzvedība. Vairāk saslimšana ir novērojama meitenēm, kā arī lielākam riskam ir pakļauti bērni, kuri ir atlēti, modeļi, baleta dejotāji. Pētījuma mērķis ir noskaidrot klīniski diagnostisk…

Bulimia nervosaĒšanas traucējumieating disordersAnorexia nervosaMedicīna
researchProduct

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methot…

1999

SUMMARYImmunosuppressive therapy with methotrexate (MTX) has been established as effective treatment for patients with rheumatoid arthritis. To analyse the therapeutic potential and mechanisms of action of MTX, we determined serum cytokine levels and cytokine production by splenic T cells and macrophages in untreated and MTX-treated mice. Furthermore, we assessed the role of MTX in a murine model of experimental arthritis induced by collagen type II (CIA). MTX reduced spontaneous and IL-15-induced tumour necrosis factor (TNF) production by splenic T cells but not by macrophages from healthy mice in vitro in a dose-dependent manner. In contrast, interferon-gamma (IFN-γ) production was less s…

CD4-Positive T-LymphocytesMalemusculoskeletal diseasesT-Lymphocytesmedicine.medical_treatmentImmunologyArthritisMice TransgenicSpleenInterferon-gammaMiceImmune systemAnimalsImmunology and AllergyMedicineheterocyclic compoundsInterferon gammaskin and connective tissue diseasesInterleukin 4Interleukin-15Mice KnockoutMice Inbred BALB CInterleukin-6Tumor Necrosis Factor-alphabusiness.industryMacrophagesOriginal ArticlesImmunotherapymedicine.diseaseArthritis ExperimentalMethotrexatemedicine.anatomical_structureCytokineMice Inbred DBAImmunologyCytokinesTumor necrosis factor alphaCollagenInterleukin-4businessImmunosuppressive AgentsSpleenmedicine.drug
researchProduct

Perspectives for CNO neutrino detection in Borexino

2018

International audience; Borexino measured with unprecedented accuracy the fluxes of solar neutrinos emitted at all the steps of the pp fusion chain. Still missing is the measurement of the flux of neutrinos produced in the CNO cycle. A positive measurement of the CNO neutrino flux is of fundamental importance for understanding the evolution of stars and addressing the unresolved controversy on the solar abundances. The measurement of the CNO neutrino flux in Borexino is challenging because of the low intensity of this component (CNO cycle accounts for about 1% of the energy emitted by Sun), the lack of prominent spectral features and the presence of background sources. The main background c…

CNO cycleexperimental methodsneutrino: solarPhysics::Instrumentation and DetectorsSolar neutrinoAstrophysics::High Energy Astrophysical Phenomenascintillation counter: liquidSolar neutrinosbismuth: admixtureAstrophysics[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]7. Clean energySolar neutrinoCNO-cycleneutrino: fluxAstrophysics::Solar and Stellar Astrophysics[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]Stellar evolutionBorexinoliquid scintillatorAstrophysics::Galaxy AstrophysicsPhysicsEnergy distributiondetectorbackgroundbismuth: nuclideCNO cycleNeutrino detector13. Climate actionBorexinoExperimental methodsNeutrino
researchProduct

Contribution to the flora of Asian and European countries: new national and regional vascular plant records, 2

2014

The paper presents new records for 20 vascular plant species from eight Asian and two European countries. Five taxa (Artemisia campestris, Artemisia tanacetifolia, Delphinium sajanense, Diarthron vasiculosum var. undulatum, Epilobium adenocaulon) are reported from Kazakhstan, four (Deyeuxia yanyuanensis, Poa arnoldii, Stipa gracilis, Stipa macroglossa subsp. kazachstanica) from China, three (Nepeta pamirensis, Silene bucharica, Scrophularia pamiro-alaica) from Uzbekistan, two (Epilobium nervosum, Stellaria zolotukhinii) from Mongolia, two (Oenothera deflexa, Scirpus georgianus) from Poland, one (Coronopus didymus) from Tajikistan, one (Orobanche rumseiana) from Italy, one (Stipa macroglossa…

CalamagrostisAsiafood.ingredientbiologynative speciesalien speciesPlant Sciencebiology.organism_classificationRanunculusAconogononEuropeCarex siderostictataxonomyfoodSporobolus cryptandrusBotanyAmorpha fruticosaStipachorologyCarduus acanthoidesActa Botanica Gallica
researchProduct

In the literature: February 2019

2019

Malignant pleural mesothelioma (MPM) is a rare and lethal cancer associated to asbestos exposure. Currently, the pemetrexed and cisplatin combination chemotherapy remains the only approved treatment. In the last 5 years, a growing knowledge on mesothelioma pathobiology has translated into the development of multiple novel therapeutic strategies.1 One of the largest reports of comprehensive genomic profiling of MPM was conducted by Bueno and colleagues. Using RNA-seq data, they identified four distinct molecular subtypes, and through exome analysis, they found that BAP1 , NF2 , TP53 , SETD2 , DDX3X , ULK2 , RYR2 , CFAP45 , SETDB1 and DDX51 were significantly mutated.2 In an article recently …

Cancer ResearchBAP1business.industryCombination chemotherapyNewslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282PemetrexedMRNA SequencingOncologySETD2DNA methylationCancer researchmedicine1506MesotheliomabusinessExomemedicine.drugESMO Open
researchProduct